Pharmacokinetic and pharmacodynamic interaction of enavogliflozin, a sodium-glucose cotransporter 2 inhibitor, with glimepiride and metformin in healthy participants.
AIMS Enavogliflozin, a sodium-glucose cotransporter 2 inhibitor, is expected to be coadministered with antihyperglycaemic drugs with different mechanisms of action. This study aimed to investigate the pharmacokinetic (PK) and pharmacodynamic (PD) interactions between enavogliflozin, glimepiride and metformin. METHODS...